Comparative Effectiveness of Neuromodulation Techniques for Managing Neurogenic Bladder in Women with MS
Recent research has explored the use of neuromodulation methods to treat neurogenic overactive bladder symptoms in women diagnosed with multiple sclerosis (MS). Two primary techniques, transcutaneous posterior tibial nerve stimulation (TPTNS) and repetitive transcranial magnetic stimulation (rTMS), have demonstrated similar levels of effectiveness in managing bladder dysfunction.
A pilot study published online on April 11 in Neurodegenerative Disease Management involved 16 female MS patients divided into two groups. Each group received one of the treatments over a period of two consecutive weeks, with a total of 10 sessions. The study aimed to assess the impact of these methods on bladder function through various urodynamic parameters and patient-reported measures.
Results indicated that neither TPTNS nor rTMS produced significant changes within or between groups regarding urodynamic parameters. However, notable improvement was observed in nocturia frequency in the TPTNS group when analyzing a three-day voiding diary. Other patient-centered assessments, including the Overactive Bladder Questionnaire-V8, Incontinence Severity Index, and Incontinence Quality of Life Scale, showed no significant differences.
The authors highlighted that both neuromodulation strategies are advantageous because they are safe, easy to administer, and free of side effects. Consequently, both TPTNS and rTMS are considered viable treatment options for women with MS experiencing neurogenic bladder symptoms.
These findings suggest that neuromodulation could be a promising avenue for symptom relief, although further research with larger sample sizes is needed to confirm long-term benefits. The study underscores the importance of patient safety and treatment accessibility in managing complex neurogenic conditions.
For more information, see the full study: Pınar Atak Çakir et al, Effect of neuromodulation on neurogenic bladder in women with multiple sclerosis: a pilot randomized controlled trial, Neurodegenerative Disease Management (2025). [DOI: 10.1080/17582024.2025.2488712].
Source: https://medicalxpress.com/news/2025-05-neuromodulation-methods-outcomes-neurogenic-bladder.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Unexpected Births: NZ Ambulance Teams Share Their Experiences During Sudden Out-of-Hospital Deliveries
New Zealand ambulance crews share their experiences managing unexpected out-of-hospital births, highlighting challenges and the importance of specialized emergency training to ensure safe deliveries.
Innovative AI Application Bridges Communication Gap for Minimally Verbal Autistic Children and Their Parents
A groundbreaking AI app named AACessTalk is transforming communication for minimally verbal autistic children, enabling deeper family connections through personalized and adaptive conversational tools.
New Insights into Tick Antiviral Defenses Could Lead to Better Control of Deadly Fever Virus
Recent research uncovers how ticks actively combat deadly viruses, revealing new targets to prevent disease transmission. Discover how natural antiviral proteins in ticks could help stop the spread of severe fever viruses.
Frontline Nurses Highlight Staffing Challenges, Language Barriers, and Profit-Driven Care Models
A new study highlights critical nurse-reported barriers to high-quality, equitable hospital care, emphasizing staffing, language access, and systemic profit motives as key challenges.